Edition:
India

Alkem Laboratories Ltd (ALKE.NS)

ALKE.NS on National Stock Exchange of India

1,704.45INR
12:53pm IST
Change (% chg)

Rs12.50 (+0.74%)
Prev Close
Rs1,691.95
Open
Rs1,700.00
Day's High
Rs1,711.00
Day's Low
Rs1,675.05
Volume
8,495
Avg. Vol
47,842
52-wk High
Rs2,268.00
52-wk Low
Rs1,670.00

Latest Key Developments (Source: Significant Developments)

India's Alkem Laboratories Dec Quarter Consol Net Profit Rises
Friday, 8 Feb 2019 

Feb 8 (Reuters) - Alkem Laboratories Ltd ::DEC QUARTER CONSOL REVENUE FROM OPERATIONS 19.25 BILLION RUPEES VERSUS 17.41 BILLION RUPEES YEAR AGO.DECLARED INTERIM DIVIDEND OF 8 RUPEES PER SHARE.DEC QUARTER CONSOL NET PROFIT 2.03 BILLION RUPEES VERSUS PROFIT 1.72 BILLION RUPEES YEAR AGO.  Full Article

Alkem Labs Gets 8 Observations From U.S. FDA Inspection At St Louis Facility
Wednesday, 6 Feb 2019 

Feb 6 (Reuters) - Alkem Laboratories Ltd ::SAYS U.S. FDA INSPECTION AT ALKEM'S MANUFACTURING FACILITY LOCATED AT ST LOUIS, USA..CO HAS RECEIVED FORM 483 THAT CONTAINS EIGHT OBSERVATIONS .  Full Article

India's Alkem Laboratories Sept-Qtr Consol Profit Falls
Friday, 2 Nov 2018 

Nov 2 (Reuters) - Alkem Laboratories Ltd ::SEPT QUARTER CONSOL PROFIT 2.54 BILLION RUPEES VERSUS PROFIT 3.21 BILLION RUPEES YEAR AGO.SEPT QUARTER CONSOL REVENUE FROM OPERATIONS 19.19 BILLION RUPEES VERSUS 18.59 BILLION RUPEES YEAR AGO.  Full Article

India's Alkem Laboratories Dec Qtr Consol Profit Falls
Friday, 9 Feb 2018 

Feb 9 (Reuters) - Alkem Laboratories Ltd ::DEC QUARTER CONSOL PROFIT 1.72 BILLION RUPEES VERSUS 2.33 BILLION RUPEES YEAR AGO.DEC QUARTER CONSOL REVENUE FROM OPERATIONS 17.40 BILLION RUPEES VERSUS 14.82 BILLION RUPEES YEAR AGO.DECLARED INTERIM DIVIDEND OF 6 RUPEES PER SHARE.  Full Article

Alkem Laboratories Announces Closure of U.S.FDA Inspection at Baddi Manufacturing Facility
Wednesday, 10 Jan 2018 

Jan 10 (Reuters) - Alkem Laboratories Ltd ::SAYS U.S. FDA ISSUES EIR FOR CO'S MANUFACTURING FACILITY AT BADDI.SAYS ‍INSPECTION OF CO'S MANUFACTURING FACILITY AT BADDI HAS NOW BEEN CLOSED BY US FDA​.IN RESPONSE TO TWO FORM 483 OBSERVATIONS ISSUED BY FDA, CO SUBMITTED DETAILED CORRECTIVE AND PREVENTIVE ACTION PLAN TO REGULATOR.  Full Article

India's Alkem Laboratories Gets Shareholders' Nod For Appointment Of Sandeep Singh As MD
Monday, 8 Jan 2018 

Jan 8 (Reuters) - Alkem Laboratories Ltd ::GETS SHAREHOLDERS' NOD FOR APPOINTMENT OF SANDEEP SINGH AS MD.GETS SHAREHOLDERS' NOD FOR RE-APPOINTMENT OF DHANANJAY KUMAR SINGH AS JOINT MD.  Full Article

India's Alkem Labs Sept-qtr consol profit rises
Friday, 10 Nov 2017 

Nov 10 (Reuters) - Alkem Laboratories Ltd ::Sept quarter consol profit 3.27 billion rupees versus 2.88 billion rupees year ago.Sept quarter consol revenue from operations 18.65 billion rupees versus 16.38 billion rupees year ago.  Full Article

India's Alkem Laboratories CEO Prabhat Agrawal resigns
Tuesday, 31 Oct 2017 

Oct 31 (Reuters) - Alkem Laboratories Ltd :Says Prabhat Agrawal resigns as CEO.  Full Article

India's Alkem Laboratories June-qtr consol net profit falls
Friday, 11 Aug 2017 

Aug 11 (Reuters) - Alkem Laboratories Ltd :June quarter consol net profit 637.8 million rupees versus profit of 2.43 billion rupees year ago.June quarter consol total income 13.25 billion rupees versus 15.09 billion rupees year ago.  Full Article

Alkem laboratories no form 483 issued by FDA after inspection at Taloja
Friday, 14 Jul 2017 

July 14 (Reuters) - Alkem Laboratories Ltd :Says US FDA had conducted an inspection at company's bioequivalence facility located at Taloja, India.Says at end of inspection at Taloja, no form 483 was issued.  Full Article